Our hypothesis about the positive role of CHI3L2 in patient prognosis is noteworthy, especially considering that CHI3L1 plays a significant role as a poor prognostic factor in various cancers such as glioma and breast cancer45. This evidence concerns the gene CHI3L2 and central nervous system cancer.